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Background: pressure ulcers, 25–30% of which are on the heels are a major burden 
to patients and healthcare systems. A better understanding of factors associated 
with healing is required to inform treatment and research priorities. 
Objectives: to identify patient and pressure ulcer characteristics associated with the 
healing of heel pressure ulcers. 
Study design and setting: patients with heel pressure ulcers were recruited to a 
prospective cohort study in a large teaching hospital in the UK, with a maximum 18-
month follow-up. Cox proportional hazards model regression analysis was used to 
identify prognostic factors for healing. 
Results: one hundred and forty of 148 patients recruited were analysed. They had 
183 pressure ulcers: 77 ulcers healed, 5 were on limbs amputated prior to ulcer 
healing, 88 were on patients who died prior to healing, 11 were present at the end of 
the study and 2 were lost to follow-up. The median time to healing was 121 (range 
8–440) days. Of 12 variables associated with healing (P ≤ 0.2), multi-variable 
analysis identified two factors which were independently predictive of healing 
including the presence of a severe (versus superficial) ulcer (hazard ratio = 0.48, P < 
0.1) and the presence of peripheral arterial disease (hazard ratio = 0.40, P < 0.1). 
Conclusions: increased ulcer severity and the presence of peripheral arterial disease 
significantly reduced the probability of healing. Treatments for heel pressure ulcers 
should consider the severity of the ulcer and the presence of peripheral arterial 
disease. 
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Introduction 
Pressure ulcers (PUs) usually occur over bony prominences such as the heel and 
sacrum [1] where there is little soft tissue. PUs result in significant suffering and 
morbidity to patients [2] and are costly to the healthcare provider. In the 
UK costs to the health and social care system are estimated as £1.77 billion [3], 
costs in the USA range between $9.1 and $11.6 billion per year [4]. 
 
Interventions for healing PUs include offloading the pressure, wound treatments and 
correcting intrinsic factors, e.g. malnutrition. A Cochrane systematic review of 
support surfaces for treating heel PUs identified only one study and did not find 
evidence to recommend any specific type of support surface [5]. No studies have 
been identified which provide sufficient evidence for other healing interventions [6]. 
 
Very few prognostic factor studies have been performed to study PU healing and 
none has looked at heel ulcers specifically [6–8]. 
 
Most of the available evidence on the process of wound healing is based on in vitro 
studies of acute wounds [9, 10]. The effects of systemic and wound conditions on 
acute wound healing are limited and are relatively unknown for PUs [6]. This study 
examined the healing of heel PUs as they are a common location, the anatomy 
differs from other body sites and lower limbs are prone to peripheral arterial disease 
(PAD) [11], neuropathy [12] and oedema [13] which are likely to affect PU healing 
and aimed to identify prognostic factors for healing heel PUs. 
 
Methods 
This was a single centre, prospective cohort study. Following informed 
consent/Consultee Agreement [14], patients aged ≥18 years with at least one heel 
ulcer of minimum Grade 2 [15] of any duration were recruited from elderly care, 
medical and surgical wards. Participants had baseline assessments and weekly 
follow-up while in hospital and monthly postdischarge until 18 months, ulcers healed, 
death or amputation. Patients were ineligible if it was thought unethical to approach 
them. 
 
An a priori sample size of 200 was based on the expected healing rate and the 
number of variables considered in the regression model, based on Harrell et al.’s 
rule of thumb (10 events per variable) [16]. 
 
The study was approved by Leeds West Research Ethics Committee in June 2006. 
Variables were identified through a review of PU, diabetic foot ulcer and venous leg 
ulcer healing prognostic factor studies. Please see Supplementary data available in 
Age and Ageing online, Appendix 1, Table S1, for information on the derivation of 
variables. These included age, gender, ethnicity, speciality, co-morbidity, nutritional 
status, smoking, medication, pain, individual Braden risk scale factors, neuropathy, 
arterial disease, ulcer severity, size, duration and tissue type and surrounding skin 
condition. All data assessments were undertaken by a consultant nurse (E.M.). 
 
The primary outcome was time to healing for each ulcer. Data were censored due to 
loss to follow-up, death, amputation of the affected limb, withdrawal from the study or 
the end of follow-up (18 months). 
 
Cox proportional hazards regression was used to measure the hazard ratio (HR) of 
potential prognostic factors. The ulcer level analysis took into account non-
independence of bilateral heel ulcers and included tests of proportional hazards 
assumption, collinearity, statistical and clinical quality [17]. See Supplementary data 
available in Age and Ageing online, Appendix 2, for details of analysis process. 
 
Results 
One hundred and forty-eight patients with 183 PUs were recruited during a 2-year 
period (August 2007 to August 2009). Following consent/Consultee Agreement, eight 
patients were withdrawn and no follow-up data were collected (Figure 1), resulting in 
analysis population of 140 patients. 
 
Half the patients were male, mean age 80 years, most were in Elderly Care 
speciality. 
 
See Supplementary data available in Age and Ageing online, Appendix 1, Tables S2, 
S3 and S4, for full details of outcomes for variables (patient demographics, clinical 
factors and ulcer-related variables, respectively). 
 
There was a wide range in ulcer duration prior to recruitment (0–1475 days). A 
quarter of the patients had neuropathy in the affected foot and only 38% had an ulcer 
on a limb with adequate arterial supply. There were similar numbers of superficial 
and severe ulcers and a wide range in ulcer size (0.24–43.14 cm2). The most 
common tissue type was necrotic, 28% of patients had healthy skin surrounding 
the ulcer and 25% reported their ulcer painful. 
 
Seventy-seven ulcers healed, 5 were on limbs amputated prior to ulcer healing, 88 
were on patients who died prior to healing, 11 were present at the end of the study 
and 2 were lost to follow-up. The median time to healing was 121 (range 
8–440) days. 
 
See Supplementary data available in Age and Ageing online, Table S5, for details of 
the univariate analysis. Analysis identified the following variables which reached 
significance at P ≤ 0.2: specialities of ‘Elderly’ and ‘Vascular’, PAD (as comorbidity), 
prescribed nutritional, analgesic or respiratory medication, PAD (as ABPI), ulcer 
severity, area, tissue type and erythema/maceration of surrounding skin. 
 
The variables: speciality of Elderly Care, PAD (comorbidity), prescribed nutritional, 
analgesics and respiratory medication, ulcer severity, ulcer area and gender, were 
entered in the multi-variable model. Other variables were excluded due to small 
numbers of observations (erythema, skin maceration), collinearity with other 
variables (vascular speciality and tissue type) or missing data. 
 
Two variables emerged as significant: severity (HR: 0.48) 95% confidence interval 
0.30–0.75 P = 0.001 and PAD (HR: 0.40) 95% confidence interval 0.20–0.81 P = 
0.010.  
 
This suggests that in a heel ulcer population, having a severe rather than a 
superficial ulcer, after controlling for the confounding effects of the presence of all 
other variables in the model, is associated with half (HR = 0.48) the chance of 
healing over time (95% CI: 0.3–0.8). The presence of PAD, also significantly reduces 
the chance of healing over time (HR: 0.4, 95% CI: 0.2–0.8) (Table 1). 
 
Discussion 
This is the first study to identify prognostic factors for healing of heel PUs. Two 
factors were identified: the severity of the ulcer and the presence of PAD, both of 
which have clinical validity. 
 
Three previous studies have examined PU healing prognostic factors including two 
retrospective studies [7, 8] and one prospective cohort study of patients with Grade 
¾ PUs [6]. None reported heel data. With the exception of Berlowitz et al. [7], who 
found PU severity to be prognostic for healing, other factors identified as 
independently prognostic of PU healing did not emerge in multi-variable modelling 
in our study of heel PU healing. However, the relevance of PAD in predicting 
outcomes has been identified in two prospective cohort studies of patients with 
diabetic foot ulcers [18, 19], confirming its validity. 
 
There are a number of strengths of this study including the prospective design, 
minimal missing data, the population was externally valid, the inclusion criteria were 
broad, comparisons of screened and recruited patients identified the main difference 
being those who were near death were not recruited (Figure 1), the study used the 
endpoint of time to complete healing had a long duration of follow-up (18 months) 
and continued to collect data following hospital discharged. The use of relative 
assent/Consultee agreement enabled those who lacked capacity, e.g. due to 
dementia, to be included, thus improving the external validity. 
 
Study limitations include: the sample size was not met due to time constraints; 
variables selected were likely correlated or surrogates for other measures, e.g. 
speciality and co-morbidity, however given the lack of evidence, the exploratory 
nature of this study and a concern for not overlooking important potential factors led 
to collection of a broad range of variables. 
 
A high number of patients died prior to healing. Similarly, a high proportion of 
patients were screened but not recruited as they were close to death (39%). This 
may also be related to the age of the population. Although no association can be 
derived in this study, the notion of ‘skin failure’ as constituent of ‘multi-organ failure’ 
associated with death has been proposed by other authors [20]. This censoring 
impacted on the amount of data included for analysis. 
 
The study has provided valuable information about heel ulcers which take a long 
time to heal, this will assist healthcare professionals (and enable them to inform 
patients) to have realistic expectations about difficult to heal wounds. It will help 
inform resource needs and enable patients and their carers to make choices about 
treatments which will affect their quality of life. Given the dominance of PAD, 
questions need to be raised about current service configuration and the potential 
benefit of vascular assessment and referral for patients with heel ulcers. It will also 
help inform future research studies, in particular trial planning by identifying study 
follow-up requirements as well as prognostic factors for analysis.  
 
This study has made an important contribution to the knowledge of healing heel PUs. 
Very few studies of prognostic factors for healing PUs on all body sites have been 




• PUs, particularly those found on the heel are predominately found in older people. 
• Ulcer severity and the presence of PAD are independent prognostic factors for 
slower healing of heel PUs. 
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Table 1. Patient baseline variables 
 
Variable/ Attribute      Total number of patients (140) 
 
Age (years)   Mean (SD)/median (range)  80 (14.0)/84 (20–102) 
Gender   Male/female     66 (47%)/74 (53%) 
Ethnicity   White British     135 (96%) 
Asian      2 (1.5%) 
Afro-Caribbean    2 (1.5%) 
Eastern European    1 (1%) 
Speciality   Care of the elderly    91 (65%) 
Vascular     17 (12%) 
Orthopaedics    11 (8%) 
Neurosciences   8 (6%) 
General surgery    9 (6%) 
Diabetology     4 (3%) 
Haemoglobin  Mean (SD)/median (range)  10.9 (1.7)/11 (6.7–15.9) 
Missing     1 
Smoking   Current/previous/never   14 (10%) / 67(48%) / 59(42%) 
Medication   Anticoagulants/antiplatelet  112 (80%) 
Cardiovascular    93 (66%) 
Endocrine     53 (38%) 
Nutrition     77 (55%) 
Steroids     12 (9%) 
Analgesics     101 (72%) 
Antibiotics     32 (23%) 
Gastrointestinal    98 (70%) 
Central nervous system   75 (54%) 
Respiratory     23 (16%) 
Obstetrics, gynaecology and  
urinary tract    10 (7%) 
Other      12 (9%) 
 
 
